Hyperimmune Colostrum and Oral Mucositis

Tel-Aviv Sourasky Medical Center30 enrolled

Overview

To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

TRIPLE

Enrollment

Conditions

Head and Neck Cancer

Interventions

hyperimmune colostrumDIETARY_SUPPLEMENT

hyperimmune colostrum

PlaceboDIETARY_SUPPLEMENT

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer. Exclusion Criteria: * Other tumors * Non-epithelial tumors * Pregnancy * Poor functional status

Locations (1)

Sourasky Medical Center

Tel Aviv, Israel

Central Contacts

Nachum Vaisman, Prof'

CONTACT

972-3-697-4807 vaisman@tasmc.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.